MAPT and Alzheimer disease: Cross-sectional studies report that obesity is linked with lower FDG-PET in patients with preclinical AD [155] and AD-related grey matter atrophy in people with AD, yet this atrophy pattern did not overlap with Aβ or tau burden [156].